We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Avacta’s Rapid Antigen Test is Confirmed To Detect SARS-CoV-2 New Variants

Product News   Mar 08, 2021

 
Avacta’s Rapid Antigen Test is Confirmed To Detect SARS-CoV-2 New Variants

Credit: CDC/ Pexels

FURTHER INFORMATION
 
 
Advertisement
 

Related Product News

Tosoh Bioscience Introduces HPLC Column

Product News

Tosoh Bioscience LLC has announced the introduction of its TSKgel FcR-IIIA-5PW HPLC column.

READ MORE

Avacta Receives Clinical Validation of AffiDX SARS-CoV-2 Antigen Lateral Flow Test

Product News

Avacta Group plc has announced positive data from the clinical validation of its AffiDX® SARS-CoV-2 antigen lateral flow test.

READ MORE

Adaptate Biotherapeutics Raises $18 million in Series A2 Funding

Product News

Adaptate Biotherapeutics has announced that its existing investors, Abingworth and Takeda Pharmaceutical Company Limited have together made a further equity investment of $18 million.

READ MORE

Like what you just read? You can find similar content on the communities below.

Diagnostics Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE